🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators objective is to assess the effectiveness of an opioid spa...
Status
Terminated
Location
Virginia Commonwealth University
Start Date
2016-07-11
Trial ID
NCT02734940
Treatments Being Tested
The purpose of this study is a comparison of pain management in opioid-tole...
Status
Completed
Location
Abbott Northwestern Hospital
Start Date
2011-09
Trial ID
NCT01447888
Treatments Being Tested
The study will evaluate the pharmaco-economic consequences of the use of a ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-09
Trial ID
NCT00158873
This study aims to assess the outcome of standardized evidence-based care t...
Status
Completed
Location
Zagazig University Faculty of Human Medicine
Start Date
2017-05-15
Trial ID
NCT04615702
Treatments Being Tested
This study is designed to determine if different doses of buprenorphine (ei...
Status
Terminated
Location
Erie County Medical Center
Start Date
2007-10
Trial ID
NCT00552578
Treatments Being Tested
This pilot trial will explore the feasibility, acceptability, and effective...
Status
Completed
Location
AppleGate Recovery El Dorado
Start Date
2024-10-14
Trial ID
NCT06023459
Treatments Being Tested
This will be a phase 2, single-center, unblinded randomized controlled pilo...
Status
Terminated
Location
Boston Children's Hospital
Start Date
2022-03-15
Trial ID
NCT04291599
Prilocaine is a local anesthetic drug which as an intermediate duration of ...
Status
Completed
Location
University Hospital Saint-Pierre, Université Libre de Bruxelles
Start Date
2014-02
Trial ID
NCT03607916
Treatments Being Tested
The project focuses on investigating problematic medication use, especially...
Status
Active Not Recruiting
Location
Akershus University Hospital
Start Date
2017-05-03
Trial ID
NCT03162081
Oral naltrexone was initially FDA approved to treat opioid use disorder and...
Status
Completed
Location
Washington University
Start Date
2019-09-01
Trial ID
NCT04409041
Treatments Being Tested